Advertisement
CHRD vs GFR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHRD is a Hold and GFR is a Buy.
CHRD saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for CHRD moved out of overbought territory on October 28, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 71 similar instances where the indicator exited the overbought zone. In 49 of the 71 cases the stock moved lower. This puts the odds of a downward move at 69%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CHRD moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 19 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHRD as a result. In 69 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for CHRD turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 33 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHRD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
CHRD broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
CHRD moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CHRD crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +5.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRD advanced for three days, in 256 of 355 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 176 of 255 cases where CHRD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.941) is normal, around the industry mean (3.856). P/E Ratio (9.718) is within average values for comparable stocks, (4.063). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (1.958). Dividend Yield (0.036) settles around the average of (0.044) among similar stocks. P/S Ratio (1.327) is also within normal values, averaging (5.980).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CHRD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 49 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
GFR in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 02, 2026
GFR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 15 of 18 cases where GFR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The 10-day moving average for GFR crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +4.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where GFR advanced for three days, in 126 of 164 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 77 of 103 cases where GFR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 34 cases where GFR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GFR as a result. In 45 of 56 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for GFR turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 30 similar instances when the indicator turned negative. In 25 of the 30 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
GFR moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GFR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.289) is normal, around the industry mean (3.856). P/E Ratio (-17.162) is within average values for comparable stocks, (4.063). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.958). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (1.755) is also within normal values, averaging (5.980).
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. GFR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GFR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
CHRD | ||
|---|---|---|
OUTLOOK RATING 1..100 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 35 Fair valued | |
PROFIT vs RISK RATING 1..100 | 49 | |
SMR RATING 1..100 | 69 | |
PRICE GROWTH RATING 1..100 | 37 | |
P/E GROWTH RATING 1..100 | 91 | |
SEASONALITY SCORE 1..100 | 48 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CHRD | GFR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | N/A |
| Stochastic ODDS (%) | 2 days ago 69% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 70% | 2 days ago 70% |
| Advances ODDS (%) | 19 days ago 72% | 9 days ago 77% |
| Declines ODDS (%) | 8 days ago 64% | 2 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 59% | 2 days ago 83% |
| Aroon ODDS (%) | 2 days ago 69% | 2 days ago 75% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHRD’s FA Score shows that 0 FA rating(s) are green while GFR’s FA Score has 1 green FA rating(s).
- CHRD’s FA Score: 0 green, 5 red.
- GFR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHRD’s TA Score shows that 4 TA indicator(s) are bullish while GFR’s TA Score has 4 bullish TA indicator(s).
- CHRD’s TA Score: 4 bullish, 6 bearish.
- GFR’s TA Score: 4 bullish, 5 bearish.
Price Growth
CHRD (@Oil & Gas Production) experienced а -5.61% price change this week, while GFR (@Oil & Gas Production) price change was -12.14% for the same time period.
The average weekly price growth across all stocks in the @Oil & Gas Production industry was -6.66%. For the same industry, the average monthly price growth was +0.46%, and the average quarterly price growth was -1.91%.
Reported Earning Dates
CHRD is expected to report earnings on Nov 04, 2026.
GFR is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Oil & Gas Production (-6.66% weekly)The oil and gas production segment includes companies that specialize in exploration, development, and production of oil and natural gas. These companies are focused on upstream operations. Companies typically identify deposits, drill wells, and extract raw materials from underground. The industry also includes related services like rig operations, feasibility studies, machinery rentals etc. Several operators in this industry work with various types of contractors such as engineering procurement and construction contractors, as well as with joint-venture partners and oil field service companies. Oil and gas often involves large fixed costs of production; so, declining crude oil prices, for example, is a potential negative for this industry. Conoco Phillips, EOG Resources, Inc. and Pioneer Natural Resources Company are some examples of companies operating in this space.
Advertisement
CHRD and
Correlation & Price change
A.I.dvisor indicates that over the last year, CHRD has been closely correlated with PR. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if CHRD jumps, then PR could also see price increases.
| Ticker / NAME | Correlation To CHRD | 1D Price Change % | ||
|---|---|---|---|---|
| CHRD | 100% | -2.42% | ||
| PR - CHRD | 86% Closely correlated | -2.28% | ||
| OVV - CHRD | 86% Closely correlated | -1.99% | ||
| DVN - CHRD | 86% Closely correlated | -2.08% | ||
| SM - CHRD | 85% Closely correlated | -2.06% | ||
| MGY - CHRD | 85% Closely correlated | -1.56% | ||
More | ||||
GFR and
Correlation & Price change
A.I.dvisor indicates that over the last year, GFR has been loosely correlated with CNQ. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if GFR jumps, then CNQ could also see price increases.